el-Naggar A - Search Results

1

p53 mutations and expression in ovarian cancers: correlation with overall survival.

Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, Bernstein L, Jones LA, Felix JC, Kreienberg R, el-Naggar A, Press MF. Wen WH, et al. Int J Gynecol Pathol. 1999 Jan;18(1):29-41. doi: 10.1097/00004347-199901000-00005. Int J Gynecol Pathol. 1999. PMID: 9891239

2

Well-differentiated serous ovarian carcinoma presenting as a breast mass: a case report and flow cytometric DNA study.

Frauenhoffer EE, Ro JY, Silva EG, el-Naggar A. Frauenhoffer EE, et al. Int J Gynecol Pathol. 1991;10(1):79-87. doi: 10.1097/00004347-199101000-00009. Int J Gynecol Pathol. 1991. PMID: 2007537

3

Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.

Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF. Saffari B, et al. Cancer Res. 1995 Dec 1;55(23):5693-8. Cancer Res. 1995. PMID: 7585656

4

Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma.

el-Naggar AK, Lai S, Luna MA, Zhou XD, Weber RS, Goepfert H, Batsakis JG. el-Naggar AK, et al. Int J Cancer. 1995 Jun 22;64(3):196-201. doi: 10.1002/ijc.2910640309. Int J Cancer. 1995. PMID: 7622308

5

Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.

Felix A, El-Naggar AK, Press MF, Ordonez NG, Fonseca I, Tucker SL, Luna MA, Batsakis JG. Felix A, et al. Hum Pathol. 1996 Jun;27(6):561-6. doi: 10.1016/s0046-8177(96)90162-8. Hum Pathol. 1996. PMID: 8666365

6

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ. Press MF, et al. J Clin Oncol. 1997 Aug;15(8):2894-904. doi: 10.1200/JCO.1997.15.8.2894. J Clin Oncol. 1997. PMID: 9256133

7

Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.

El-Naggar AK, Lai S, Clayman G, Lee JK, Luna MA, Goepfert H, Batsakis JG. El-Naggar AK, et al. Am J Pathol. 1997 Dec;151(6):1767-74. Am J Pathol. 1997. PMID: 9403727 Free PMC article.

8

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

Reles A, Wen WH, Schmider A, Gee C, Runnebaum IB, Kilian U, Jones LA, El-Naggar A, Minguillon C, Schönborn I, Reich O, Kreienberg R, Lichtenegger W, Press MF. Reles A, et al. Clin Cancer Res. 2001 Oct;7(10):2984-97. Clin Cancer Res. 2001. PMID: 11595686

9

Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis.

Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK. Choi HR, et al. Hum Pathol. 2002 Feb;33(2):158-64. doi: 10.1053/hupa.2002.30722. Hum Pathol. 2002. PMID: 11957139

10

Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas.

Saffari B, Bernstein L, Hong DC, Sullivan-Halley J, Runnebaum IB, Grill HJ, Jones LA, El-Naggar A, Press MF. Saffari B, et al. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):952-63. doi: 10.1111/j.1525-1438.2005.00159.x. Int J Gynecol Cancer. 2005. PMID: 16174251 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,096 results

Search Page

Filters